摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6I-amidosuccinyl-6I-deoxy-2I,3I-di-O-methylhexakis(2II-VII,3II-VII,6II-VII-tri-O-methyl)cyclomaltoheptaose

中文名称
——
中文别名
——
英文名称
6I-amidosuccinyl-6I-deoxy-2I,3I-di-O-methylhexakis(2II-VII,3II-VII,6II-VII-tri-O-methyl)cyclomaltoheptaose
英文别名
6I-succinmonoamido-6I-deoxy-2I,3I-di-O-methylhexakis(2II-VII,3II-VII,6II-VII-tri-O-methyl)cyclomaltoheptaose;6VII-succcinyl-6VII-deoxy-2VII,3VII-di-O-methyl-hexakis(2,3,6-tri-O-methyl)-cyclomaltoheptaose;6I-amidosuccinyl-6I-deoxy-2I,3I-di-O-methylhexakis(2I-VII,3I-VII,6II-VII-tri-O-methyl)cyclomaltoheptaose;4-oxo-4-[[(1R,3R,5R,6R,8R,10R,11R,13R,15R,16R,18R,20R,21R,23R,25R,26R,28R,30R,31R,33R,35R,36S,37R,38S,39R,40S,41R,42S,43R,44S,45R,46S,47R,48S,49R)-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecamethoxy-10,15,20,25,30,35-hexakis(methoxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontan-5-yl]methylamino]butanoic acid
6<sup>I</sup>-amidosuccinyl-6<sup>I</sup>-deoxy-2<sup>I</sup>,3<sup>I</sup>-di-O-methylhexakis(2<sup>II-VII</sup>,3<sup>II-VII</sup>,6<sup>II-VII</sup>-tri-O-methyl)cyclomaltoheptaose化学式
CAS
——
化学式
C66H115NO37
mdl
——
分子量
1514.62
InChiKey
LPAFCBSJAMOKER-JXIXRUBCSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -4.9
  • 重原子数:
    104
  • 可旋转键数:
    31
  • 环数:
    21.0
  • sp3杂化的碳原子比例:
    0.97
  • 拓扑面积:
    380
  • 氢给体数:
    2
  • 氢受体数:
    37

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Amphiphilic cyclodextrin derivatives, method for preparation thereof and uses thereof
    申请人:Perly Bruno
    公开号:US20070142324A1
    公开(公告)日:2007-06-21
    The invention relates to cyclodextrin derivatives of formula (I): in which: R 1 ═—NH-E-AA-(L 1 ) p (L 2 ) q where E=a linear or branched Cl-Cl 5 hydrocarbon-based group with, optionally, one or more hetero atoms; AA=the residue of an amino acid; L 1 and L 2 =a C 6 -C 24 hydrocarbon-based group with, optionally, one or more hetero atoms; p and q=0 or 1, at least one being ≠0; R 2 ═H, —CH 3 , isopropyl, hydroxypropyl, sulphobutyl ether; R 3 ═H or R 2 , except when R 2 =hydroxypropyl; all the R 4 ═—OH or R 2 , except when R 2 =hydroxypropyl, or at least one of the R 4 ═R 1 ; n=5, 6 or 7. The invention also relates to a process for preparing them, and to inclusion complexes and organized surfactant systems comprising them.
    该发明涉及以下式(I)的环糊精衍生物: 其中: R 1 ═—NH-E-AA-(L 1 ) p (L 2 ) q 其中E=线性或支链的Cl-Cl 5 碳氢基团,可选地,含有一个或多个杂原子;AA=氨基酸的残基;L 1 和L 2 =含有一个或多个杂原子的C 6 -C 24 碳氢基团;p和q=0或1,至少一个不等于0; R 2 ═H,—CH 3 ,异丙基,羟丙基,磺丁基醚; R 3 ═H或R 2 ,除非R 2 =羟丙基; 所有的R 4 ═—OH或R 2 ,除非R 2 =羟丙基,或者至少一个R 4 ═R 1 ;n=5、6或7。该发明还涉及一种制备它们的方法,以及包含它们的包合物和有序表面活性剂系统。
  • Diesterification of 3-[(β-Cyclodextrinyl)succinamido]propane-1,2-diol Catalysed by Lipase: Diastereoselectivity or Tridimensional Substrate Specificity?
    作者:Cédric Gervaise、Véronique Bonnet、Florian Nolay、Christine Cézard、Imane Stasik、Catherine Sarazin、Florence Djedaïni-Pilard
    DOI:10.1002/ejoc.201402414
    日期:2014.10
    catalyzed by immobilized lipase from Mucor miehei occurred with very different conversions of the two diastereoisomers [(R)- or (S)-amidopropanediol]. The highest conversion observed with the (S)-amidopropanediol can be related to either lipase diastereoselectivity or substrate specificity. To investigate the diastereoselectivity of the lipase, diastereoisomers of the methylated β-cyclodextrin were replaced
    3-[(β-环糊精基)琥珀酰胺基]丙烷-1,2-二醇与脂肪酯的酯交换反应由来自Mucor miehei的固定化脂肪酶催化,两种非对映异构体[(R)-或(S)-酰氨基丙二醇的转化率非常不同。 ]。使用 (S)-酰氨基丙二醇观察到的最高转化率可能与脂肪酶非对映选择性或底物特异性有关。为了研究脂肪酶的非对映选择性,甲基化β-环糊精的非对映异构体被甲基化吡喃葡萄糖苷或甲基亮氨酸取代。没有观察到脂肪酶对非对映异构体的区分。进行分子建模以评估脂肪酶对两种非对映异构体的选择性。
  • Nanoparticles based on lipidyl-β-cyclodextrins: synthesis, characterization, and experimental and computational biophysical studies for encapsulation of atazanavir
    作者:Aurélien L. Furlan、Sébastien Buchoux、Yong Miao、Vincent Banchet、Mathieu Létévé、Virginie Lambertyn、Jean Michel、Catherine Sarazin、Véronique Bonnet
    DOI:10.1039/c8nj03237h
    日期:——

    After showing tensioactive properties of the compounds, the formation, stability and morphology of nanoparticles were demonstrated.

    展示了化合物的表面活性特性后,展示了纳米颗粒的形成、稳定性和形态。
  • Solvent-free chemo-enzymatic synthesis of fatty acyl-β-cyclodextrin
    作者:Véronique Bonnet、Audrey Favrelle、Frédéric Aubry、Catherine Sarazin、Florence Djedaïni-Pilard
    DOI:10.1007/s10847-012-0229-2
    日期:2013.12
    Lipase-catalyzed transesterifications were carried out without solvent and in mild conditions on permethylated β-cyclodextrins derivatives to obtain lipidyl-cyclodextrin, a new class of amphiphilic compounds with expected auto-assembly properties. Good conversion rate, of 6I-(N-hydroxyethylsuccinamido)-6I-deoxy-2I, 3I-di-O-methyl-hexakis (2II–VII,3II–VII,6II–VII-tri-O-methyl) cyclomaltoheptaose were obtained by using lipozyme as catalyst. Critical Aggregation Concentrations of these new derivatives of amphiphilic cyclodextrins (5.10−3 and 5.10−4 M) are in favor of an auto-association behavior. Finally, NMR experiments were carried out to evaluate the self-assembly of the compounds in water. The resulting supramolecular aggregates have potential to be used as nano-carriers for drug.
    脂肪酶催化的酯交换反应在无溶剂和温和条件下对全甲基化的β-环糊精衍生物进行,以获得脂质-环糊精,这是一类具有预期自组装特性的两亲化合物。使用脂肪酶作为催化剂,得到了良好的转化率,6I-(N-羟乙基琥珀酰胺基)-6I-脱氧-2I, 3I-二-O-甲基-六六糖(2II–VII,3II–VII,6II–VII-三-O-甲基)。这些新型的两亲性环糊精衍生物的临界聚集浓度(5.10−3和5.10−4 M)有利于自我关联行为。最后,进行了核磁共振实验,以评估化合物在水中的自组装情况。所得到的超分子聚集体有潜力用作药物的纳米载体。
  • Synthesis and inclusion properties study of some mono 6-amino β-cyclodextrin dimers bridged by N,N-succinyldiamide linkers
    作者:Celine Hocquelet、Christopher K. Jankowski、Andre Lucien Pelletier、Jean-Claude Tabet、Christine Lamouroux、Patrick Berthault
    DOI:10.1007/s10847-010-9816-2
    日期:2011.2
    Methylated and partially methylated cyclodextrin homo- and heterodimers linked by diamidosuccinic bridges were synthesised and their inclusion properties were evaluated using NMR and isothermic microcalorimetric measurements ITC. The selective binding of ligands, such as bisadamantyl derivatives, to the cavities of unprotected cyclodextrin dimers showed the equimolar formation of bidendate inclusion complexes (2:2, two ligand guest to two cavities host).
    合成了通过二氨基丁二酸桥连接的甲基化和部分甲基化环糊精同二聚体和异二聚体,并使用核磁共振和等温微量热测量法(ITC)评估了它们的包合特性。配体(如双金刚烷基衍生物)与未受保护的环糊精二聚体空腔的选择性结合显示,双端酸盐包合物的形成是等摩尔的(2:2,两个配体客体对两个空腔主体)。
查看更多

同类化合物

霉酚酸苯酚beta-D-葡糖苷 阜孢霉素B 阜孢杀菌素 蔗糖棕榈酸酯 蔗糖四异硬脂酸酯 蔗糖七月桂酸酯 药喇叭(IPOMOEAPURGA)树脂 硫脂I 石斛碱;青藤碱 环戊羧酸,1-氨基-2-甲基-,(1R,2S)-rel- 海藻糖 6,6'-二山嵛酸酯 木松香II 木松香I 单岩藻糖基乳糖-N-四糖 二唾液酸乳-N-四糖 乳糖醛酸 乙醋化己二酸双淀粉 中文名称暂缺 β-D-呋喃果糖基-α-D-吡喃葡萄苷二硬脂酸酯 Β-D-呋喃果糖基-Α-D-吡喃葡糖苷十二酸双酯 alpha-D-吡喃葡萄糖基-alpha-D-吡喃葡萄糖苷 6-(3-羟基-2-十四烷基十八烷酸酯) [(3aR,5R,5aR,8aS,8bR)-2,2,7,7-四甲基四氢-3aH-二[1,3]二噁唑并[4,5-b:4',5'-d]吡喃-5-基]甲基丁酸酯(non-preferredname) [(2R,3S,4S,5R,6R)-6-[(2R,3R,4S,5S,6R)-6-(十六烷酰氧基甲基)-3,4,5-三羟基四氢吡喃-2-基]氧基-3,4,5-三羟基四氢吡喃-2-基]甲基十六烷酸酯 [(2R,3S,4S,5R)-3,4-二羟基-2,5-二(羟基甲基)四氢呋喃-2-基][(2R,3S,4S,5R,6S)-3,4,5,6-四羟基四氢吡喃-2-基]甲基2-甲基-4-(2-甲基癸-1-烯-4-基)己二酸酯 [(2R,3R,4S,5R,6R)-6-[[(1R,2R,3R,4R,6R)-2,3-二羟基-5,8-二氧杂双环[4.2.0]辛烷-4-基]氧基]-3,4,5-三羟基四氢吡喃-2-基]甲基3-羟基-2-十四烷基十八烷酸酯 N-乙酰基-硫代胞壁酰-丙氨酰-异谷氨酰胺 N-(O-alpha-D-甘露糖基-(1-3)-O-(O-alpha-D-甘露糖基-(1->3)-O-(alpha-D-甘露糖基-(1-6))-alpha-D-甘露糖基-(1-6))-O-beta-D-甘露糖基-(1->4)-O-2-(乙酰氨基)-2-脱氧-beta-D-吡喃葡萄糖基-(1->4)-2-(乙酰氨基)-2-脱氧-beta-D-吡喃葡萄糖基)-L-天冬氨酰胺 L-缬氨酰-L-丙氨酰-L-缬氨酰甘氨酰-L-α-谷氨酰-L-α-谷氨酰-L-脯氨酰甘氨酰-L-脯氨酰-N~5~-(二氨基甲亚基)-L-鸟氨酸酰胺 D-甘露糖基-(1-6)-D-甘露糖基-(1-4)-2-乙酰氨基-2-脱氧-D-吡喃葡萄糖基-(1-4)-2-乙酰氨基-1-N-(4'-L-天冬氨酰)-2-脱氧-beta-D-吡喃葡萄糖基胺 D-(+)-海藻糖6-单油酸酯 9,10-二氯-2,6-二甲基蒽 8-甲氧基羰基辛基2-O-(aL-呋喃基呋喃糖基)-3-O-(aD-吡喃半乳糖基)-bD-吡喃半乳糖苷 6-山慈菇甙A 6-O-alpha-D-吡喃半乳糖基-D-葡萄糖酸 6,6'-二((2R,3R)-3-羟基-2-十四烷基十八烷酸酯)-海藻糖 4H-吡咯并[3,2,1-脱]蝶啶,5,6-二氢-4,5-二甲基-(9CI) 4-嘧啶甲腈,2-苯基- 4-[[(2R)-2-羟基-3,3-二甲基-4-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基]氧基丁酰基]氨基]丁酸 4-[6-(1,2-二羟基乙基)-3,4,5-三羟基-四氢吡喃-2-基]氧基-2,3,5-三羟基-7,8-二氧代-辛酸 3-O-棕榈酰-beta-D-呋喃果糖基2,3-二-O-棕榈酰-alpha-D-吡喃葡萄糖苷 3-(6H-苯并[b][1,5]苯并噁噻庚英-6-基)丙基-二甲基-铵2-羟基-2-羰基-乙酸酯 2-脱氧-3-O-[(3R)-3-羟基十四烷酰基]-2-{[(3R)-3-羟基十四烷酰基]氨基}-1-O-膦酰-alpha-D-吡喃葡萄糖 2-氨基-6-[[3,5,6-三羟基-2-氧代-4-[3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基]氧基己基]氨基]己酸 2-氨基-4-氧代-4-[[3,4,5-三羟基-6-[[3,4,5-三羟基-6-[[3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基]氧基甲基]四氢吡喃-2-基]氧基甲基]四氢吡喃-2-基]氨基]丁酸 2-N-(羧基丙基氨基)-2-脱氧葡萄吡喃糖 2,6-二甲基-6-(3-O-(beta-吡喃葡萄糖基)-4-O-(2-甲基丁酰基)alpha-阿拉伯吡喃糖基氧基)-2,7-辛二烯酸 1-二甲胺基萘-5-磺酰-甘氨酰-赖氨酰-酪氨酰-丙氨酰-脯氨酰-色氨酰-缬氨酸 1-O,2-O,3-O-三(3-硝基丙酰基)-alpha-D-吡喃葡萄糖 1,1-O-(4,6-二羟基-1,2-亚苯亚甲基)-4-O-[6-O-(1-氧代-2,4-癸二烯基)-beta-D-吡喃半乳糖基]-alpha-D-吡喃葡萄糖3-(7-羟基-8,14-二甲基十六碳-2,4,8,10-四烯酸酯) (Z,Z)-甲基-D-吡喃葡糖苷-2,6-二油酸酯